We are live on ! Find out more
S

SignatureFD Portfolio holdings

AUM $7.49B
1-Year Est. Return 24.82%
This Fund
S&P 500
This Quarter Est. Return
+6.43%
1 Year Est. Return
+24.82%
3 Year Est. Return
+73.56%
5 Year Est. Return
+79.97%
10 Year Est. Return
+256.52%
AUM
$1.35B
AUM Growth
+$137M
Cap. Flow
+$72.8M
Cap. Flow %
5.38%
Top 10 Hldgs %
59.71%
Holding
2,379
New
211
Increased
969
Reduced
524
Closed
145

Sector Composition

Rank Sector Weight
1 Financials 5.71%
2 Technology 5.69%
3 Consumer Staples 4.7%
4 Consumer Discretionary 4.47%
5 Healthcare 4.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EW icon
351
Edwards Lifesciences
EW
$47.8B
$309K 0.02%
3,975
+213
+6% +$16.6K
INFO
352
DELISTED
IHS Markit Ltd. Common Shares
INFO
$308K 0.02%
4,083
+354
+9% +$25.2K
IAU icon
353
iShares Gold Trust
IAU
$63.4B
$305K 0.02%
10,521
+1,598
+18% +$45.3K
NXPI icon
354
NXP Semiconductors
NXPI
$67.6B
$305K 0.02%
2,395
-69
-3% -$8.01K
SCHX icon
355
Schwab US Large- Cap ETF
SCHX
$71.1B
$305K 0.02%
23,790
+4,026
+20% +$49.3K
IBB icon
356
iShares Biotechnology ETF
IBB
$9.44B
$304K 0.02%
2,526
+1,425
+129% +$159K
SRE icon
357
Sempra
SRE
$59.7B
$304K 0.02%
4,020
+110
+3% +$8.07K
TIF
358
DELISTED
Tiffany & Co.
TIF
$303K 0.02%
2,268
-1,118
-33% -$132K
BCS icon
359
Barclays
BCS
$96.3B
$301K 0.02%
31,591
+2,143
+7% +$18.5K
EA icon
360
Electronic Arts
EA
$52.4B
$300K 0.02%
2,795
+41
+1% +$4.07K
SPDW icon
361
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$39.8B
$300K 0.02%
9,569
+91
+1% +$2.77K
VRTX icon
362
Vertex Pharmaceuticals
VRTX
$122B
$300K 0.02%
1,369
+143
+12% +$28.9K
DGRO icon
363
iShares Core Dividend Growth ETF
DGRO
$42.8B
$299K 0.02%
7,100
APH icon
364
Amphenol
APH
$184B
$298K 0.02%
11,000
+1,628
+17% +$41.6K
COO icon
365
Cooper Companies
COO
$13.7B
$298K 0.02%
3,716
+176
+5% +$13.3K
STLA icon
366
Stellantis
STLA
$16.5B
$298K 0.02%
20,264
+237
+1% +$3.43K
MKC icon
367
McCormick & Company Non-Voting
MKC
$13.6B
$297K 0.02%
3,494
+1,514
+76% +$125K
XLF icon
368
State Street Financial Select Sector SPDR ETF
XLF
$56.7B
$296K 0.02%
9,624
-12
-0.1% -$352
SON icon
369
Sonoco
SON
$5.8B
$290K 0.02%
4,699
-816
-15% -$48.3K
VEDL
370
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
$289K 0.02%
33,440
+14,828
+80% +$124K
EWT icon
371
iShares MSCI Taiwan ETF
EWT
$9.99B
$288K 0.02%
+7,000
New +$276K
MGA icon
372
Magna International
MGA
$18.3B
$288K 0.02%
5,243
+123
+2% +$6.67K
APO icon
373
Apollo Global Management
APO
$71.6B
$286K 0.02%
6,000
+5,000
+500% +$213K
ROP icon
374
Roper Technologies
ROP
$37.1B
$286K 0.02%
806
-51
-6% -$17.6K
DFS
375
DELISTED
Discover Financial Services
DFS
$285K 0.02%
3,361
-271
-7% -$22.4K

Similar funds

SignatureFD's Q4 2019 Portfolio in Review

As of Q4 2019, SignatureFD held 2,379 positions worth $1.35B, up 11% from $1.22B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

SignatureFD deployed $72.8M of net new capital in Q4 2019, opening 211 new positions and adding to 969 existing holdings. Its largest new stake was Castle Biosciences: 16,132 shares worth $554K.

By sector, the portfolio is most concentrated in Financials at 5.7% of assets, down from 5.8% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was UBS E-TRACS Alerian MLP Infrastructure ETN, an estimated $43M trimmed.

  • SignatureFD's largest Q4 2019 buy was Castle Biosciences: 16,132 shares worth $554K.
  • SignatureFD added most to iShares MSCI USA Value Factor ETF in Q4 2019, an estimated $22.2M increase.
  • SignatureFD's biggest Q4 2019 reduction was UBS E-TRACS Alerian MLP Infrastructure ETN, cutting an estimated $43M.
  • SignatureFD fully exited Berkshire Hathaway Class A in Q4 2019, selling an estimated $1.87M.
  • SignatureFD's ten largest holdings make up 60% of its $1.35B portfolio in Q4 2019.
  • SignatureFD opened 211 new positions and closed 145 in Q4 2019.
  • SignatureFD's portfolio value rose 11% quarter-over-quarter to $1.35B.

Based on SignatureFD's 13F filing for Q4 2019, filed 5 Feb 2020.